DOCSLIB.ORG

Can Arginine and Omithine Support Gut Functions? Gut: First Published As 10.1136/Gut.35.1 Suppl.S42 on 1 January 1994

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Can Arginine and Omithine Support Gut Functions? Gut: First Published As 10.1136/Gut.35.1 Suppl.S42 on 1 January 1994 S42 Gut 1994; supplement 1: S42-S45 Can arginine and omithine support gut functions? Gut: first published as 10.1136/gut.35.1_Suppl.S42 on 1 January 1994. Downloaded from L Cynober Abstract Metabolism of arginine and related Arginine and ornithine are precursors of compounds in the gut nitric oxide and polyamines, respectively. Arginine synthesis and catabolism in specific These metabolites intimately participate in tissues is conditioned by the presence of permeability and adaptive responses ofthe arginosuccinase and arginase respectively, but gut. The liver possesses high arginase only periportal hepatocytes and, to some activity as an intrinsic part of urea synthe- extent, certain brain areas, possess all the sis and would consume most of the portal enzymes required for arginine recycling and supply ofdietary arginine. The gut reduces urea synthesis.' The gut acts as a user of this possibility by converting dietary arginine because it possesses arginase (isoen- arginine to citrulline, which effectively zyme II) and ornithine carbamoyltransferase.4 bypass the liver and is resynthesised to The gut thus releases urea and citrulline.5 arginine in the kidney. Dietary ornithine In addition, enterocytes express omithine supplementation, in the form of ornithine decarboxylase6 and an NADPH2 dependent a-ketoglutarate (OKG) can be considered arginine deiminase78 which respectively lead to as an arginine precursor. Several supple- local production of aliphatic polyamines and ment studies have shown both amino acids nitric oxide. to promote growth hormone and insulin Despite the high omithine decarboxylase secretion with anabolic effects in post- activity in enterocytes, however, most of the operative patients. Their intermediary omithine produced from arginine is released metabolites (for example, glutamine, pro- into the portal blood stream, and polyamine line) may also be of benefit in trauma formation accounts for a small part of arginine metabolism. Specific effects of either consumption.8 amino acid on the gut are poorly reported. After 14C-ornithine is given by the enteral One recent animal study showed improved route, 14C-proline, '4C-glutamate, and 14C- morphology after OKG administration, polyamines are detected,9 as expected, but, in perhaps through increased polyamine contrast with arginine administration, no secretion. Generation of nitric oxide from citrulline is produced. This could suggest a arginine has two facets. Excess production degree of metabolic compartmentalisation, from high dose arginine potentiated the arginine flux being directed preferentially http://gut.bmj.com/ effects of experimentally induced sepsis, towards ornithine and citrulline production. whereas low doses improved survival. Indeed, omithine translocase, omithine These considerations suggest that the role carbamoyltransferase, and citrulline trans- of enteral diet supplementation with locase function as a multienzyme complex' arginine or OKG should be urgendy exam- (Fig 1). Figure 2 summarises arginine and ined for any benefits it may have on omithine pathways in the gut. mucosal barrier function. on September 27, 2021 by guest. Protected copyright. (Gut 1994; supplement 1: S42-S45) Arginine and related compounds in artificial nutrition For many years, arginine and related com- Arginine has multiple biological properties, pounds (omithine and citrulline) have been including the ability to stimulate anabolic considered solely as intermediate metabolites hormone secretion: intravenous and enteral in the process of nitrogen detoxification - that arginine administration increases both insulin is, in the context of ureagenesis. There is and human growth hormone secretion.'2 renewed interest, however, in these amino Several studies (reviewed in references 2 and Laboratoire de acids because ureagenesis may have an 13) show that arginine given to patients as well Biochimie, Groupe de role in homeostasis' Recherche en important pH and also as in various experimental stress models, acts Nutrition because arginine becomes an essential amino by improving nitrogen balance, accelerating Exp6rimentale et acid during growth and catabolic states.2 wound healing, and restoring depressed Metabolisme Hepatique, H6pital Ornithine is not a constituent of proteins, but immunity (Table). These effects are seen 15 Saint - Antoine, Paris, is clearly important in the regulation of nutri- whether arginine is given orally'4 or paren- France, and Centre de tional state as a precursor of aliphatic terally. 16 Recherche en In in the form of the a Nutrition Humaine, polyamines. addition, Omithine shares with arginine the ability to Clermont-Ferrand, ketoglutarate salt, omithine generates multiple stimulate human growth hormone secretion.3 France metabolic effects, which do not result solely In addition, omithine as its ao-ketoglutarate salt L Cynober to the additive action of the two moieties (OKG) generates various molecules (for Correspondence to: of this molecule.3 There is, however, a paucity example, glutamine) 17 which play a key part in Professor L Cynober, of data on the role of or its metabolites Laboratoire de Biochimie, arginine the control of protein metabolism.'8 OKG has Faculte de Pharmacie, 28 in the maintenance of gut function and been shown to improve nitrogen balance in Place H Dunant, BP38, this 63001 Clermont-Ferrand morphology; indicates possible future various acute and chronic malnutrition states Cedex, France. research directions. (see reference 3 for a review). OKG increases Can arginine and ornithine support gutfunctions? S43 53 Nitric oxide Cytoplasm Mitochondria arginine -..4citruiline Gut: first published as 10.1136/gut.35.1_Suppl.S42 on 1 January 1994. Downloaded from urea I AKU rT- Ia Polyamines ornithine carbamoyl P CIT .putrescine glutamate P5C proline spermidine a ketoglutarate Polyamines GLU spermine Co2 PRO Figure 2: Arginine and ornithine metabolic pathways in the enterocyte. Adaptedfrom Blachier et al.8, Seiler et al,'O Figure 1: Arginine (ARG) and ornithine (ORN) fluxes andJones. 1 1 (I Arginase (EC 3.5.3. 1); 2 ornithine compared. ASe=arginase; OT=ornithine translocase; decarboxylase (EC 4.1.1.17); (a ornithine CT=citrulline translocase; OCT=ornithine carbamoyl- carbamoyltransferase (EC 2.1.3.3); (v) arginine deiminase; transferase; GLU=glutamate; PRO=proline. () ornithine aminotransferase (EC 2.6.1.13). muscle protein anabolism in moderate cata- citrulline in the gut can also be seen as a means bolic states'9 and reduces protein catabolism of protecting this amino acid from excessive in hypercatabolic states.20 degradation in the liver. Finally, arginine and ornithine metabolism in enterocytes could par- ticipate in the support of gut morphology and Arginine and ornithine in the support of function by the synthesis of polyamines and gut functions nitric oxide, as will be discussed. FUNCTIONS OF ARGININE AND ORNITHINE Arginine from dietary proteins is thus actively ACTIONS OF ARGININE AND ORNITHINE metabolised in the enterocyte and supports Surprisingly, published works contain few several gut functions. Firstly, arginine metabo- studies dealing with the effects of arginine on http://gut.bmj.com/ lism in the enterocyte serves to remove excess gut function and morphology. With regard to arginine, although the liver also has a high ornithine, only one recent study is available capacity for arginine transport and metabol- (F Raul, personal communication). Rats were ism.21 It has been shown22 that portal arginine starved for three days and then fed for four concentrations rise with the percentage of pro- days by continuous enteral nutrition, with or tein in the diet, with a parallel increase in urea without supplementation with ornithine (032 synthesis. In fact, arginine acts in the hepato- g/kg/day) as the oa-ketoglutarate salt. Rats were on September 27, 2021 by guest. Protected copyright. cyte as a positive modulator of N-acetylgluta- then killed and intestinal morphology and mate synthesis, which is the allosteric enzyme content were studied. Ornithine led to obligatory activator of carbamoyl phosphate a significantly higher crypt height in the synthetase, the enzyme participating in the first jejunum and ileum and a higher total villous step of urea synthesis.1 Thus, arginine metabo- height in the ileum. In addition, sucrase and lism in the gut should be seen as a means of lactase contents were higher in the ileum of limiting arginine supply to the liver, thereby ornithine supplemented rats. limiting ureagenesis when protein intake is low. It is noteworthy that the intestine also contains significant concentrations ofN-acetylglutamate POSSIBLE MECHANISMS OF ACTION (IF ANY) (20% ofliver content),23 which must play a part As described, enterocytes are well equipped to in favouring citrulline formation from omithine convert arginine into ornithine and to after food intake. Interestingly, citrulline metabolise ornithine into putrescine and other uptake by the liver is low, and citrulline is aliphatic polyamines. Alternatively, arginine extensively converted into arginine in the kid- is the precursor of nitric oxide by arginine ney (Figure 3). Thus, arginine metabolism into desiminase. Effects ofarginine supplementation in enteral nutrition The polyamine pathway _ protein catabolism in trauma (humans/rats) Ornithine is converted into putrescine by t immune response after trauma (humans/rats) Tthymic weight ornithine decarboxylase (EC 4.1.1.17), which tthymic lymphocyte content is the rate limiting enzyme in polyamine Tlymphocyte mitotic
Load more

Recommended publications
  • Free Amino Acids in Human Amniotic Fluid. a Quantitative Study by Ion-Exchange Chromatography
    Pediat. Res. 3: 1 13-120 (1969) Amino acids fetus amniotic fluid pregnancy Free Amino Acids in Human Amniotic Fluid. A Quantitative Study by Ion-Exchange Chromatography HARVEYL. LEVY[^^] and PAULP. MONTAG Department of Neurology, Harvard Medical School; the Joseph P. Kennedy Jr. Memorial Laboratories, Massachusetts General Hospital, Boston, Massachusetts; and the Worcester Hahnemann Hospital, Worcester, Massachusetts, USA Extract Amniotic fluid was collected at inductive amniotomy or just prior to delivery following full-term uncomplicated pregnancies. Table I lists the means, ranges, and standard deviations for the concen- trations of amino acids obtained by ion-exchange chromatography of 16 specimens of amniotic fluid. Each specimen contained the following 22 amino acids: taurine, aspartic acid, threonine, serine, glutamine, proline, glutamic acid, citrulline, glycine, alanine, a-aminobutyric acid, valine, cystine, methionine, isoleucine, tyrosine, phenylalanine, ornithine, lysine, histidine, and arginine. In addition, tryptophan, which could not be detected by the ion-exchange chromatographic method employed, was found in each specimen by paper chromatography. The amino acids present in amniotic fluid were the same as those found in samples of maternal vein, umbilical artery, and umbilical vein serum (table 11). Comparisons were made in the concentrations of several amino acids among amniotic fluid, maternal serum, umbilical artery and vein serum, and perinatal urine (table 11).Taurine was present in considerably greater concentration in amniotic fluid than in maternal serum. This amino acid is also present in large quantities in umbilical artery and vein serum (table 11) and is by far the greatest single contributor to the total free amino acid pool in perinatal urine [I].
    [Show full text]
  • The Relationship Between Citrulline Accumulation and Salt Tolerance During the Vegetative Growth of Melon (Cucumis Melo L.)
    The relationship between citrulline accumulation and salt tolerance during the vegetative growth of melon (Cucumis melo L.) H.Y. Dasgan1, S. Kusvuran1, K. Abak1, L. Leport2, F. Larher2, A. Bouchereau2 1Department of Horticulture, Agricultural Faculty, Cukurova University, Adana, Turkey 2Université de Rennes 1, Campus de Beaulieu, Agrocampus Rennes, Rennes Cedex, France ABSTRACT Citrulline has been recently shown to behave as a novel compatible solute in the Citrullus lanatus (Cucurbitaceae) growing under desert conditions. In the present study we have investigated some aspects of the relationship which might occur in leaves of melon seedlings, also known to produce citrulline, between the capacity to accumulate this ureido amino acid and salt tolerance. With this end in view, salt-induced changes at the citrulline level have been compared in two melon genotypes exhibiting contrasted abilities to withstand the damaging effects of high salinity. Progressive salinization of the growing solution occurred at 23 days after sowing. The final 250 mmol/l external NaCl concentration was reached within 5 days and further maintained for 16 days. In response to this treatment, it was found that the citrulline amount increased in fully expanded leaves of both genotypes according to different ki- netics. The salt tolerant genotype Midyat was induced to accumulate citrulline 4 days before the salt sensitive Yuva and as a consequence the final amount of this amino acid was twice higher in the former than in the latter. Compa- red with citrulline, the free proline level was found to be relatively low and the changes induced in response to the salt treatment exhibited different trends according to the genotypes under study.
    [Show full text]
  • Dietary Supplements Compendium 2019 Edition
    Products and Services New Dietary Supplements Reference Standards Below is a list of newly released Reference Standards. Herbal Medicines/ Botanical Dietary Supplements Baicalein Baicalein 7-O-Glucuronide Chebulagic Acid Dietary Supplements Compendium 2019 Edition Coptis chinensis Rhizome Dry Extract In response to the customer feedback, coupled with evolving information needs, USP moved the Psoralen Dietary Supplements Compendium (DSC) to an online platform for the 2019 edition. DSC continues Scutellaria baicalensis Root Dry to provide in-depth, comprehensive information for all phases of development and manufacturing of Extract quality dietary supplements including quality control, quality assurance, and regulatory/compendial Terminalia chebula Fruit Dry affairs. Extract Guarana Seed Dry Extract Some of the advantages that come with the new online DSC edition include: Cullen Corylifolium Fruit Dry Extract More frequent updates to ensure access to the most current information Procyanidin B2 Customizable alerts to notify of changes to selected documents An intuitive interface to facilitate quick and easy navigation Non-Botanicals A customizable workspace with bookmarks, alerts and a viewing history beta-Glycerylphosphorylcholine Convenient, anytime, anywhere access with common browsers Conjugated Linoleic Acids – In addition to selected new and revised monographs and General Chapters from the USP-NF and Triglycerides Food Chemicals Codex issued since the previous 2015 edition, the DSC 2019 features: Creatine Docosahexaenoic Acid 24 new General Chapters Eicosapentaenoic Acid 72 new dietary ingredient and dietary supplement monographs L-alpha- 27 sets of supplementary information for botanical and nonbotanical dietary supplements Glycerophosphorylethanolamine 59 updated botanical HPTLC plates L-alpha- Revised and updated dietary intake comparison tables Glycerylphosphorylcholine Updated Dietary Supplement Verification Program manual Omega-3 Free Fatty Acids Pyrroloquinoline Quinone View this page for more information or to subscribe to the 2019 online DSC.
    [Show full text]
  • I ANALYSIS of L- CITRULLINE, L-ARGININE and L-GLUTAMIC
    i ANALYSIS OF L- CITRULLINE, L-ARGININE AND L-GLUTAMIC ACID IN SELECTED FRUITS, VEGETABLES, SEEDS AND NUTS SOLD IN NAIROBI CITY COUNTY, KENYA PENINNAH MUENI MULWA (B.Ed. (Sc)) I56/29384/2014 A Thesis Submitted in Partial Fulfillment of the Requirements for the Award of the Degree of Master of Science (Chemistry) in the School of Pure and Applied Sciences, Kenyatta University NOVEMBER, 2019 ii DECLARATION I hereby declare that this thesis is my original work and has not been presented for award of a degree or examination at any other University Signature ……………………………….. Date ………………… PENINNAH MUENI MULWA DEPARTMENT OF CHEMISTRY SUPERVISORS We confirm that the work referred in this thesis was carried by the candidate with our approval as University supervisors Prof. Wilson Njue Signature …………………Date …………………….. Department of Chemistry Kenyatta University Dr. Margaret Mwihaki Ng’ang’a Signature ……..............Date ……………. Department of Chemistry Kenyatta University iii DEDICATION This work is dedicated to my beloved daughter, Blessing Mumo, my father Stephen Mulwa, my mother Agnes Mulwa, my sisters Tracy and Josphine for their encouragement, moral and spiritual support as i travelled through the research journey. iv ACKNOWLEDGEMENTS First, I would like to thank the Almighty God for granting me grace to carry out the research work successfully. I am indeed grateful and would like to express my sincere appreciation to my supervisors Prof. Wilson Njue and Dr. Margaret Mwihaki Ng’ang’a both of Department of Chemistry, Kenyatta University for their tireless effort and many hours of guidance throughout the course of study. I am highly indebted to technicians, John Kamathi of Jomo Kenyatta University of Agriculture and Technology (JKUAT) and Jane Mburu, Department of Chemistry, Kenyatta University (KU) for their technical support during the LC-MS analysis of the samples.
    [Show full text]
  • The Diagnosis and Management of Ornithine Transcarbamylase Deficiency in Pregnancy: a Case Report
    Perinatal Journal 2011;19(1):23-27 e-Adress: http://www.perinataljournal.com/20110191006 doi:10.2399/prn.11.0191006 The Diagnosis and Management of Ornithine Transcarbamylase Deficiency in Pregnancy: A Case Report Orkun Çetin1, Cihat fien1, Begüm Aydo¤an1, Seyfettin Uluda¤1, ‹pek Dokurel Çetin2, Hakan Erenel1 1Cerrahpafla T›p Fakültesi Kad›n Hastal›klar› ve Do¤um Anabilim Dal›, ‹stanbul, Türkiye 2Cerrahpafla T›p FakültesiÇocuk Sa¤l›¤› ve Hastal›klar› Anabilim Dal›, ‹stanbul Türkiye Abstract Objective: Ornithine transcarbamylase (OTC) deficiency is the most common urea cycle disorder. In our case, we discussed the fol- low up and the management of the OTC deficiency patient, diagnosed during pregnancy. Case: 32-year-old patient, OTC deficiency was diagnosed during pregnancy which was resulted with missed abortion. In the next pregnancy, the patient treated with phenyl butyrate, arginin ornitin lisin and carbamazepine. Coryon villus sampling (CVS) was done in the first trimester. There was not any mutation in the fetal gene locus. In the 39. gestational week, healthy female baby was deliv- ered by caesarean section. Conclusion: OTC deficiency is a rare disease. To make the followup and the management of these patients during pregnancy, may require knowledge and experience about complications. The treatment must be carried out with multidisciplinary approach. The genetic counseling should be given to the family about the prenatal diagnosis of OTC deficiency (CVS, amniosentesis). Keywords: Ornithine transcarbamylase deficiency, pregnancy, prenatal diagnosis, multidisciplinary approach. Gebelikte ornitin transkarbamilaz eksikli¤i tan›s› ve yönetimi: Olgu sunumu Amaç: Ornitin transkarbamilaz (OTC) eksikli¤i, en s›k rastlanan üre döngüsü bozuklu¤udur.
    [Show full text]
  • Characterization of High-Ornithine-Producing Weissella Koreensis DB1 Isolated from Kimchi and Its Application in Rice Bran Fermentation As a Starter Culture
    foods Article Characterization of High-Ornithine-Producing Weissella koreensis DB1 Isolated from Kimchi and Its Application in Rice Bran Fermentation as a Starter Culture Mun So Yeong , Moon Song Hee and Chang Hae Choon * Kimchi Research Center, Department of Food and Nutrition, Chosun University, 309 Pilmun-daero, Dong-gu, Gwangju 61452, Korea; [email protected] (M.S.Y.); [email protected] (M.S.H.) * Correspondence: [email protected] Received: 11 September 2020; Accepted: 23 October 2020; Published: 26 October 2020 Abstract: High-ornithine-producing Weissella koreensis DB1 were isolated from kimchi. Ornithine is produced from arginine via the intracellular arginine deiminase pathway in microorganisms; thus, high cell growth is important for producing ornithine in large quantities. In this study, excellent W. koreensis DB1 growth (A600: 5.15–5.39) was achieved in de Man, Rogosa, and Sharpe (MRS) medium supplemented with 1.0–3.0% arginine (pH 5.0) over 24–48 h at 30 ◦C, and the highest ornithine (15,059.65 mg/L) yield was obtained by culture in MRS containing 3.0% arginine for 48 h. W. koreensis DB1 was further investigated as a functional starter culture for rice bran fermentation. After 48 h of fermentation at 30 ◦C, the fermented rice bran was freeze-dried and ground. The prepared fermented rice bran contained 43,074.13 mg/kg of ornithine and 27,336.37 mg/kg of citrulline, which are used as healthcare supplements due to their beneficial effects. Furthermore, the organoleptic quality of the fermented rice bran was significantly improved, and the fermented product contained viable cells (8.65 log CFU/mL) and abundant dietary fiber.
    [Show full text]
  • L-Citrulline
    L‐Citrulline Pharmacy Compounding Advisory Committee Meeting November 20, 2017 Susan Johnson, PharmD, PhD Associate Director Office of Drug Evaluation IV Office of New Drugs L‐Citrulline Review Team Ben Zhang, PhD, ORISE Fellow, OPQ Ruby Mehta, MD, Medical Officer, DGIEP, OND Kathleen Donohue, MD, Medical Officer, DGIEP, OND Tamal Chakraborti, PhD, Pharmacologist, DGIEP, OND Sushanta Chakder, PhD, Supervisory Pharmacologist, DGIEP, OND Jonathan Jarow, MD, Advisor, Office of the Center Director, CDER Susan Johnson, PharmD, PhD, Associate Director, ODE IV, OND Elizabeth Hankla, PharmD, Consumer Safety Officer, OUDLC, OC www.fda.gov 2 Nomination • L‐citrulline has been nominated for inclusion on the list of bulk drug substances for use in compounding under section 503A of the Federal Food, Drug and Cosmetic Act (FD&C Act) • It is proposed for oral use in the treatment of urea cycle disorders (UCDs) www.fda.gov 3 Physical and Chemical Characterization • Non‐essential amino acid, used in the human body in the L‐form • Well characterized substance • Soluble in water • Likely to be stable under ordinary storage conditions as solid or liquid oral dosage forms www.fda.gov 4 Physical and Chemical Characterization (2) • Possible synthetic routes – L‐citrulline is mainly produced by fermentation of L‐arginine as the substrate with special microorganisms such as the L‐arginine auxotrophs arthrobacterpa rafneus and Bacillus subtilis. – L‐citrulline can also be obtained through chemical synthesis. The synthetic route is shown in the scheme below. This
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Increased Citrulline Amino Aciduria/Urea Cycle Disorder
    Newborn Screening ACT Sheet Increased Citrulline Amino Aciduria/Urea Cycle Disorder Differential Diagnosis: Citrullinemia I, argininosuccinic acidemia; citrullinemia II (citrin deficiency), pyruvate carboxylase deficiency. Condition Description: The urea cycle is the enzyme cycle whereby ammonia is converted to urea. In citrullinemia and in argininosuccinic acidemia, defects in ASA synthetase and lyase, respectively, in the urea cycle result in hyperammonemia and elevated citrulline. Medical Emergency: Take the Following IMMEDIATE Actions Contact family to inform them of the newborn screening result and ascertain clinical status (poor feeding, vomiting, lethargy, tachypnea). Immediately consult with pediatric metabolic specialist. (See attached list.) Evaluate the newborn (poor feeding, vomiting, lethargy, hypotonia, tachypnea, seizures and signs of liver disease). Measure blood ammonia. If any sign is present or infant is ill, initiate emergency treatment for hyperammonemia in consultation with metabolic specialist. Transport to hospital for further treatment in consultation with metabolic specialist. Initiate timely confirmatory/diagnostic testing and management, as recommended by specialist. Initial testing: Immediate plasma ammonia, plasma quantitative amino acids. Repeat newborn screen if second screen has not been done. Provide family with basic information about hyperammonemia. Report findings to newborn screening program. Diagnostic Evaluation: Plasma ammonia to determine presence of hyperammonemia. In citrullinemia, plasma amino
    [Show full text]
  • Leucine and Citrulline in Human Muscle Protein Synthesis
    LEUCINE AND CITRULLINE IN HUMAN MUSCLE PROTEIN SYNTHESIS NUTRITIONAL AND CONTRACTILE REGULATION OF HUMAN MUSCLE PROTEIN SYNTHESIS: ROLE OF LEUCINE AND CITRULLINE By TYLER A. CHURCHWARD-VENNE, B.A. (HONS); M.Sc. A Thesis Submitted to the School of Graduate Studies in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy McMaster University © Copyright by Tyler A. Churchward-Venne, 2013 DOCTOR OF PHILOSOPHY (2013) McMaster University (Kinesiology) Hamilton, Ontario TITLE: Nutritional and contractile regulation of human muscle protein synthesis: role of leucine and citrulline. AUTHOR: Tyler A. Churchward-Venne, B.A. (Hons) (York University); M.Sc. (The University of Western Ontario). SUPERVISOR: Dr. Stuart M. Phillips SUPERVISORY COMMITTEE: Dr. Martin J. Gibala Dr. Gianni Parise NUMBER OF PAGES: 203 ii ABSTRACT Amino acids are key nutritional stimuli that are both substrate for muscle protein synthesis (MPS), and signaling molecules that regulate the translational machinery. There is a dose-dependent relationship between protein intake and MPS that differs between young and elderly subjects. The current thesis contains results from three separate studies that were conducted to examine to potential to enhance smaller doses of protein, known to be suboptimal in their capacity to stimulate MPS, through supplementation with specific amino acids, namely leucine and citrulline. The first two studies examined the potential to enhance the muscle protein synthetic capacity of a smaller, suboptimal dose of whey protein with leucine. In study one, we concluded that leucine supplementation of a suboptimal dose of protein could render it as effective at enhancing rates of MPS as ~four times as much protein (25 g) under resting conditions, but not following resistance exercise.
    [Show full text]
  • Tri-Amino™ Support for Healthy Function of Muscle and Vascular Systems
    PRODUCT DATA DOUGLAS LABORATORIES® 04/2012 1 Tri-Amino™ Support for healthy function of muscle and vascular systems DESCRIPTION Tri-Amino™, provided by Douglas Laboratories, includes significant amounts of the amino acids L-ornithine, L-arginine, and L-lysine. FUNCTIONS Amino acids have many functions in the body. They are the building blocks for all body proteins—structural proteins that build muscle, connective tissues, bones and other structures, and functional proteins in the form of thousands of metabolically active enzymes. Amino acids provide the body with the nitrogen that is essential for growth and maintenance of all tissues and structures. Aside from these general functions, individual amino acids also have specific functions in many aspects of human physiology and biochemistry. L-arginine is a conditionally essential dibasic amino acid. The body is usually capable of producing sufficient amounts of arginine, but in times of physical stress, endogenous synthesis is often inadequate to meet the increased demands. L-arginine can either be used for glucose synthesis or catabolized to produce energy via the tricarboxylic acid cycle. It is also the sole source of nitric oxide (NO), via the enzyme nitric oxide synthase. NO can affect a variety of physiological processes, including relaxation of arterial smooth muscle, platelet aggregation, and neuroendocrine secretion. L-arginine is required for the synthesis of creatine phosphate. Similar to adenosine triphosphate (ATP), creatine phosphate functions as a carrier of readily available energy for contractile work in muscles. Adequate reservoirs of creatine phosphate are necessary in muscle as an energy reserve for anaerobic activity. L-arginine is also a precursor of polyamines, including putrescine, spermine and spermidine.
    [Show full text]
  • Serum Metabolite Profiles As Potential Biochemical Markers in Young
    www.nature.com/scientificreports OPEN Serum metabolite profles as potential biochemical markers in young adults with community- acquired pneumonia cured by moxifoxacin therapy Bo Zhou1, Bowen Lou2,4, Junhui Liu3* & Jianqing She2,4* Despite the utilization of various biochemical markers and probability calculation algorithms based on clinical studies of community-acquired pneumonia (CAP), more specifc and practical biochemical markers remain to be found for improved diagnosis and prognosis. In this study, we aimed to detect the alteration of metabolite profles, explore the correlation between serum metabolites and infammatory markers, and seek potential biomarkers for young adults with CAP. 13 Eligible young mild CAP patients between the ages of 18 and 30 years old with CURB65 = 0 admitted to the respiratory medical department were enrolled, along with 36 healthy participants as control. Untargeted metabolomics profling was performed and metabolites including alcohols, amino acids, carbohydrates, fatty acids, etc. were detected. A total of 227 serum metabolites were detected. L-Alanine, 2-Hydroxybutyric acid, Methylcysteine, L-Phenylalanine, Aminoadipic acid, L-Tryptophan, Rhamnose, Palmitoleic acid, Decanoylcarnitine, 2-Hydroxy-3-methylbutyric acid and Oxoglutaric acid were found to be signifcantly altered, which were enriched mainly in propanoate and tryptophan metabolism, as well as antibiotic-associated pathways. Aminoadipic acid was found to be signifcantly correlated with CRP levels and 2-Hydroxy-3-methylbutyric acid and Palmitoleic acid with PCT levels. The top 3 metabolites of diagnostic values are 2-Hydroxybutyric acid(AUC = 0.90), Methylcysteine(AUC = 0.85), and L-Alanine(AUC = 0.84). The AUC for CRP and PCT are 0.93 and 0.91 respectively.
    [Show full text]